Lara Meisner - 12 Sep 2024 Form 3 Insider Report for Bicara Therapeutics Inc. (BCAX)

Role
Chief Legal Officer
Signature
/s/ Lara Meisner
Issuer symbol
BCAX
Transactions as of
12 Sep 2024
Transactions value $
$0
Form type
3
Filing time
12 Sep 2024, 21:20:18 UTC
Previous filing
20 Jun 2023
Next filing
18 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BCAX Stock Option (Right to Buy) 12 Sep 2024 Common Stock 156K $5.45 Direct F1
holding BCAX Stock Option (Right to Buy) 12 Sep 2024 Common Stock 97.4K $5.45 Direct F2
holding BCAX Stock Option (Right to Buy) 12 Sep 2024 Common Stock 135K $9.24 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vest on November 27, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F2 The shares underlying this option vest in sixteen equal quarterly installments following December 14, 2023, subject to the Reporting Person's continued service on each such vesting date.
F3 The shares underlying this option vest in sixteen equal quarterly installments following August 6, 2024, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney